Tokyo, Japan

Yuichi Arimoto

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Asahi Kasei Pharma Corporation. Active years: 2009-2010.


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2009-2010

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yuichi Arimoto: Innovator in Pharmaceutical Crystallization

Introduction

Yuichi Arimoto is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical crystallization, holding a total of 2 patents. His work focuses on improving the methods of producing specific crystalline forms of substituted phenylalkanoic acids.

Latest Patents

Arimoto's latest patents include innovative methods for producing crystals of substituted phenylalkanoic acids. One patent details the production of crystals from compounds such as 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionic acid and methyl 3-[4-(indan-2-yloxy)-3-(1-methyl-1H-indazol-5-yl)-5-nitrophenyl]propionate. These methods aim to enhance the efficacy of these compounds when used as medicines. Another patent focuses on the crystal forms of these compounds and the processes for their production, providing improved methods for pharmaceutical applications.

Career Highlights

Yuichi Arimoto is currently employed at Asahi Kasei Pharma Corporation, where he continues to advance his research in pharmaceutical sciences. His work has been instrumental in developing better methods for producing pharmaceutical compounds, which can lead to more effective treatments.

Collaborations

Arimoto collaborates with esteemed colleagues such as Naoyuki Ishii and Motoshi Shoda. Their combined expertise contributes to the innovative research and development efforts at Asahi Kasei Pharma Corporation.

Conclusion

Yuichi Arimoto's contributions to the field of pharmaceutical crystallization are noteworthy. His patents reflect a commitment to improving medicinal compounds through innovative crystallization methods. His work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…